SCHEMBL23544262

SCHEMBL23544262

Cc1nonc1CN(N)c1nc(OCC(C)(C)C)nc(N2CCC(F)(F)C2)c1N

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23544237 0.80 CNR2 (0.49) CNR2
SCHEMBL20611053 0.77 CNR2 (0.61) CNR2
SCHEMBL23544260 0.76 CNR2 (0.63) CNR2
SCHEMBL16554645 0.75 CNR2 (1.00) CNR2
SCHEMBL16212163 0.75 CNR2 (0.80) CNR2
SCHEMBL23544261 0.68 CNR2 (0.56) CNR2
SCHEMBL20611264 0.68 CNR2 (0.60) CNR2
SCHEMBL23544272 0.68 CNR2 (0.60) CNR2
SCHEMBL20611306 0.67 CNR2 (0.59) CNR2
SCHEMBL20610961 0.67 CNR2 (0.58) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3483163-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES AS CB2 RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2021-06-23 EP disclosed